Managing food protein–induced enterocolitis syndrome during the coronavirus disease 2019 pandemic: Expert recommendations

Medical Advisory Board of the International FPIES Association

doi:10.1016/j.anai.2020.04.032

Managing food protein–induced enterocolitis syndrome during the coronavirus disease 2019 pandemic: Expert recommendations

Medical Advisory Board of the International FPIES Association

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	14-16
Number of pages	3
Journal	Annals of Allergy, Asthma and Immunology
Volume	125
Issue number	1
DOIs	https://doi.org/10.1016/j.anai.2020.04.032
State	Published - Jul 2020
Externally published	Yes

Access to Document

10.1016/j.anai.2020.04.032

Cite this

@article{f05d9c1c66014326ba9c86e0730c8487,

title = "Managing food protein–induced enterocolitis syndrome during the coronavirus disease 2019 pandemic: Expert recommendations",

author = "{Medical Advisory Board of the International FPIES Association} and Anna Nowak-Wegrzyn and Antonella Cianferoni and Bird, {J. A.} and Alessandro Fiocchi and Caubet, {Jean Christoph} and Stefania Arasi and Barad, {Ashis V.} and Theresa Bingemann and Terri Brown-Whitehorn and Raquel Durban and Todd Green and George Konstantinou and Stephanie Leonard and Jennifer Lightdale and Antonella Muraro and Ichiro Nomura and Jonathan Spergel and Carina Venter",

note = "Funding Information: Disclosures: Dr Nowak-Wegrzyn reports to have received research support from the National Institute of Allergy and Infectious Diseases, DBV Technologies, Astellas Pharma, and Danone and Nestle; received consultancy fees from Regeneron and Gerber Institute; serves as the deputy editor for the Annals of Allergy, Asthma, and Immunology; and serves as Chair of the Medical Advisory Board of the International Food Protein–Induced Enterocolitis Syndrome Association. Dr Fiocchi reports receiving research support from Danone , Sanofi , Hipp, Ferrero, and Galbusera S.p.A.; and has served on advisory boards for Danone , Stallergenes, Abbott , DBV , Novartis , Hipp, and International Food Protein–Induced Enterocolitis Syndrome Association. Dr Bird reports receiving research support from National Institute of Health–National Institute of Allergy and Infectious Diseases, Genentech , Food Allergy Research and Education , Aimmune Therapeutics, Astellas , and DBV Technologies; and has served on advisory boards for AllerGenis, Prota Therapeutics, and Food Allergy Research and Education . The remaining authors have no conflicts of interest to report. Funding Information: Disclosures: Dr Nowak-Wegrzyn reports to have received research support from the National Institute of Allergy and Infectious Diseases, DBV Technologies, Astellas Pharma, and Danone and Nestle; received consultancy fees from Regeneron and Gerber Institute; serves as the deputy editor for the Annals of Allergy, Asthma, and Immunology; and serves as Chair of the Medical Advisory Board of the International Food Protein?Induced Enterocolitis Syndrome Association. Dr Fiocchi reports receiving research support from Danone, Sanofi, Hipp, Ferrero, and Galbusera S.p.A.; and has served on advisory boards for Danone, Stallergenes, Abbott, DBV, Novartis, Hipp, and International Food Protein?Induced Enterocolitis Syndrome Association. Dr Bird reports receiving research support from National Institute of Health?National Institute of Allergy and Infectious Diseases, Genentech, Food Allergy Research and Education, Aimmune Therapeutics, Astellas, and DBV Technologies; and has served on advisory boards for AllerGenis, Prota Therapeutics, and Food Allergy Research and Education. The remaining authors have no conflicts of interest to report.",

year = "2020",

month = jul,

doi = "10.1016/j.anai.2020.04.032",

language = "English",

volume = "125",

pages = "14--16",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

number = "1",

}

TY - JOUR

T1 - Managing food protein–induced enterocolitis syndrome during the coronavirus disease 2019 pandemic

T2 - Expert recommendations

AU - Medical Advisory Board of the International FPIES Association

AU - Nowak-Wegrzyn, Anna

AU - Cianferoni, Antonella

AU - Bird, J. A.

AU - Fiocchi, Alessandro

AU - Caubet, Jean Christoph

AU - Arasi, Stefania

AU - Barad, Ashis V.

AU - Bingemann, Theresa

AU - Brown-Whitehorn, Terri

AU - Durban, Raquel

AU - Green, Todd

AU - Konstantinou, George

AU - Leonard, Stephanie

AU - Lightdale, Jennifer

AU - Muraro, Antonella

AU - Nomura, Ichiro

AU - Spergel, Jonathan

AU - Venter, Carina

N1 - Funding Information: Disclosures: Dr Nowak-Wegrzyn reports to have received research support from the National Institute of Allergy and Infectious Diseases, DBV Technologies, Astellas Pharma, and Danone and Nestle; received consultancy fees from Regeneron and Gerber Institute; serves as the deputy editor for the Annals of Allergy, Asthma, and Immunology; and serves as Chair of the Medical Advisory Board of the International Food Protein–Induced Enterocolitis Syndrome Association. Dr Fiocchi reports receiving research support from Danone , Sanofi , Hipp, Ferrero, and Galbusera S.p.A.; and has served on advisory boards for Danone , Stallergenes, Abbott , DBV , Novartis , Hipp, and International Food Protein–Induced Enterocolitis Syndrome Association. Dr Bird reports receiving research support from National Institute of Health–National Institute of Allergy and Infectious Diseases, Genentech , Food Allergy Research and Education , Aimmune Therapeutics, Astellas , and DBV Technologies; and has served on advisory boards for AllerGenis, Prota Therapeutics, and Food Allergy Research and Education . The remaining authors have no conflicts of interest to report. Funding Information: Disclosures: Dr Nowak-Wegrzyn reports to have received research support from the National Institute of Allergy and Infectious Diseases, DBV Technologies, Astellas Pharma, and Danone and Nestle; received consultancy fees from Regeneron and Gerber Institute; serves as the deputy editor for the Annals of Allergy, Asthma, and Immunology; and serves as Chair of the Medical Advisory Board of the International Food Protein?Induced Enterocolitis Syndrome Association. Dr Fiocchi reports receiving research support from Danone, Sanofi, Hipp, Ferrero, and Galbusera S.p.A.; and has served on advisory boards for Danone, Stallergenes, Abbott, DBV, Novartis, Hipp, and International Food Protein?Induced Enterocolitis Syndrome Association. Dr Bird reports receiving research support from National Institute of Health?National Institute of Allergy and Infectious Diseases, Genentech, Food Allergy Research and Education, Aimmune Therapeutics, Astellas, and DBV Technologies; and has served on advisory boards for AllerGenis, Prota Therapeutics, and Food Allergy Research and Education. The remaining authors have no conflicts of interest to report.

PY - 2020/7

Y1 - 2020/7

UR - http://www.scopus.com/inward/record.url?scp=85084617067&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2020.04.032

DO - 10.1016/j.anai.2020.04.032

M3 - Article

C2 - 32387170

AN - SCOPUS:85084617067

SN - 1081-1206

VL - 125

SP - 14

EP - 16

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 1

ER -